Archana De - Concepedia

Author

Archana De

University of Kansas Medical Center

Also Known As

A De, A U De, Archana De, Smita Mehta

Publications

567

Citations

H-Index

Concepts

All Affiliations

University of Kansas Medical Center Kansas City VA Medical Center North Dakota State University Biomedical Research Foundation University of Maryland, Baltimore

About

Archana De is an author at University of Kansas Medical Center specializing in cell biology, tumor biology, and cancer biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	231
2	Cell Biology	5	5	231
3	Cancer Cell Biology	4	4	152
4	Pathology	1	1	56
5	Pharmacology	1	1	20

Archana De

Publications

482

Citations

H-Index

Page 1

	Year	Citations
Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis Inamul Haque, Smita Mehta, Monami Majumder, Molecular Cancer	2011	114
Emblica officinalis Extract Induces Autophagy and Inhibits Human Ovarian Cancer Cell Proliferation, Angiogenesis, Growth of Mouse Xenograft Tumors Alok De, Archana De, Chris J. Papasian, PLoS ONE	2013	81
Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition Gargi Maity, Archana De, Amlan Das, Laboratory Investigation Breast OncologyDevelopmental BiologyTumor-initiating CellsMedicineCell-matrix Interaction	2015	79
The Matricellular Protein CCN1/Cyr61 Is a Critical Regulator of Sonic Hedgehog in Pancreatic Carcinogenesis Inamul Haque, Archana De, Monami Majumder, Journal of Biological Chemistry PathologyCell ProliferationCcn1 MrnaCancer BiologySonic Hedgehog	2012	56
CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27Kip1 via Skp2 and FOXO3a regulation Inamul Haque, Sushanta K. Banerjee, Archana De, Oncogene Signal TransductionSignaling PathwayFoxo3a RegulationCell RegulationMedicine	2014	43
<i>Emblica officinalis</i>extract downregulates pro-angiogenic molecules<i>via</i>upregulation of cellular and exosomal miR-375 in human ovarian cancer cells Alok De, Benjamin D. Powers, Archana De, Oncotarget	2016	33
CCN5 activation by free or encapsulated EGCG is required to render triple‐negative breast cancer cell viability and tumor progression Amlan Das, Inamul Haque, Priyanka Ray, Pharmacology Research & Perspectives Breast OncologyNanotherapeuticsChemoprevention StrategyTumor ProgressionCell Death	2021	33
CCN5 Activation by free or encapsulated-EGCG is required to Render Triple-negative breast cancer cell Viability and Tumor Progression Amlan Das, Inamul Haque, Priyanka Ray, Breast OncologyNanotherapeuticsChemoprevention StrategyTumor ProgressionCcn5 Activation	2022	20
Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets Alok De, Archana De, Ramratan Sharma, Journal of Cancer	2020	13
pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model Debasmita Dutta, Priyanka Ray, Archana De, PLoS ONE	2024	10

Page 1